Deutsche Bank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Deutsche Bank's BMY Position: Q2 2026 in Review
Deutsche Bank increased its Bristol-Myers Squibb (BMY) stake by 12% in Q2 2026, buying an estimated $63.5M and bringing the position to 10,143,181 shares worth $584M. The position accounts for 0.17% of the portfolio, ranked #120.
Deutsche Bank first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.39B in Q2 2022. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Deutsche Bank held 10,143,181 shares of Bristol-Myers Squibb worth $584M as of Q2 2026.
- Deutsche Bank bought 1,106,696 Bristol-Myers Squibb shares in Q2 2026, an estimated $63.5M.
- Bristol-Myers Squibb made up 0.17% of Deutsche Bank's portfolio in Q2 2026, its #120 holding.
- Deutsche Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- Deutsche Bank's Bristol-Myers Squibb position peaked at $1.39B in Q2 2022.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.